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and 2Universite´ de Strasbourg/Centre National de la Recherche Scientifique, UMR7177, Institut de Chimie, Strasbourg, FranceABSTRACT Mislocalization and aggregation of the huntingtin protein are related to Huntington’s disease. Its first exon—more
specifically the first 17 amino acids (Htt17)—is crucial for the physiological and pathological functions of huntingtin. It regulates
huntingtin’s activity through posttranslational modifications and serves as an anchor to membrane-containing organelles of
the cell. Recently, structure and orientation of the Htt17 membrane anchor were determined using a combined solution and
solid-state NMR approach. This prompted us to refine this model by investigating the dynamics and thermodynamics of this
membrane anchor on a POPC bilayer using all-atom, explicit solvent molecular dynamics and Hamiltonian replica exchange.
Our simulations are combined with various experimental measurements to generate a high-resolution atomistic model for the
huntingtin Htt17 membrane anchor on a POPC bilayer. More precisely, we observe that the single a-helix structure is more
stable in the phospholipid membrane than the NMR model obtained in the presence of dodecylphosphocholine detergent
micelles. The resulting Htt17 monomer has its hydrophobic plane oriented parallel to the bilayer surface. Our results further
unveil the key residues interacting with the membrane in terms of hydrogen bonds, salt-bridges, and nonpolar contributions.
We also observe that Htt17 equilibrates at a well-defined insertion depth and that it perturbs the physical properties—order
parameter, thickness, and area per lipid—of the bilayer in a manner that could favor its dimerization. Overall, our observations
reinforce and refine the NMR measurements on the Htt17 membrane anchor segment of huntingtin that is of fundamental
importance to its biological functions.INTRODUCTIONHuntingtin is an ubiquitous protein of 3114 amino acids
fundamental to the embryonic development (1) and is
involved, for example, in intracellular vesicular and
organelles trafficking (2) such as regulating autophagy
in response to endoplasmic reticulum stress (3), protein
scaffolding (4), and transcription and axonal transport (5).
It has attracted considerable attention over the last few
decades due to its relation to Huntington’s disease, a
CAG/glutamine repeat disorder (6–9). Indeed, it contains
a segment of consecutive glutamines (QN) at its amino-
terminus that, when expressed with >~36 repeating resi-
dues, leads to the aggregation of huntingtin, in a dominant
manner, causing deleterious effects through various nuclear
and extranuclear pathways (10,11). It has been observed that
amino-terminus fragments generated by proteolytic cleav-
age of huntingtin accumulate in the nucleus and are involved
in the pathogenesis of Huntington’s disease (12–14). The
first exon of huntingtin is sufficient to reproduce neurolog-
ical phenotypes and aggregation features characteristic of
Huntington’s disease in vivo (15,16) and in vitro (17–19).
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0006-3495/15/03/1187/12 $2.00segment of 17 amino acids (Htt17), a segment of consecu-
tive glutamines (QN), and a segment rich in prolines.
The Htt17 segment of the first exon is of fundamental
importance. It acts as a membrane anchor that modulates
the localization of huntingtin to specific membrane-contain-
ing organelles of the cell such as the endoplasmic reticulum
(20), the mitochondria, and the Golgi (21). Htt17 also acts as
a nuclear export sequence that regulates the localization of
huntingtin between the cytoplasm and the nucleus (22,23).
It interacts with the TRiC chaperonin to suppress the aggre-
gation of huntingtin (24). And it can undergo posttrans-
lational modifications such as SUMOylation (25) and
phosphorylation (26–29) that modulate the toxicity, clear-
ance, localization, and function of huntingtin. This small
segment also accelerates the fibrillation kinetics (24,30)
and changes the nucleation and the oligomer structures
(31,32) of the amyloidogenic QN segment (33). These
observations indicate that Htt17 is crucial to huntingtin
physiological and pathological functions.
In aqueous solution, circular dichroism (CD) experiments
show that the Htt17 segment populates 10–50% of a-helix
depending on the aqueous buffer used (20,24,34,35).
Solution nuclear magnetic resonance (NMR) studies further
indicate that it does not sample any stable secondary
structure motif (24). Taken together, these results suggest
that Htt17 likely populates a wide range of helix/coilhttp://dx.doi.org/10.1016/j.bpj.2015.02.001
TABLE 1 Summary of the performed simulations
Simulations
Phospholipid
force field Type
Initial
configuration Time (ns)
Htt17_nmr Berger MD NMR 1000  11
Htt17_a Berger MD a 1000  11
Htt17_nmr_slipids SLIPIDS MD NMR 1000  2
Htt17_a_slipids SLIPIDS MD a 1000  2
Htt17_nmr_hrex Berger HREX NMR 500  16  1
Htt17_a_hrex Berger HREX a 250  16  3
All simulations are done in the NPTensemble and are started from the same
hexagonal prism periodic cell (a ¼ 90; b ¼ 90; g ¼ 120; a ¼ 7.73 nm;
b ¼ 7.73 nm, and c ¼ 9.24 nm) containing 8982 water molecules and 167
phospholipids. For the HREX simulation, the number of replicas is 16, as
specified in the last column. The AMBER99sb*-ILDN/Berger simulations
are presented in the main text, and those using AMBER99sb*-ILDN/
SLIPIDS in the Supporting Material. The Htt17_nmr_hrex and two of the
Htt17_a_hrex simulations are presented in the Supporting Material.
1188 Coˆte´ et al.configurations. In contrast, Htt17 appears to form an a-helix
in a crystal structure of a fusion protein consisting of the
maltose-binding protein and huntingtin exon 1 (MBP-
Htt17Q17-ex1) (36). Complementing these in vitro experi-
ments, various computational methods investigated the
configurational ensemble of Htt17 and its impact on QN at
the atomic level. While some observe that Htt17 forms an
a-helix in aqueous solution by its own (37) and attached
to QN (38), most observe that Htt17 is, for the most part,
unstructured by its own (34,39–41) and attached to QN
(34,42,43). Htt17 also modulates the structure (34,40) and
the aggregation (44) of QN oligomers.
In apolar solution, there is a significant increase of the
a-helix population as shown by CD spectroscopy when
adding trifluoroethanol, dodecylphosphocholine (DPC)
detergent micelles, or lipid vesicles to aqueous buffers
(20,24,35). Early studies postulated that Htt17’s ability to
form an a-helix upon binding to a phospholipid bilayer is en-
coded in its amphipathic amino acid sequence (20). Indeed,
as an a-helix, the Htt17 has all its nonpolar amino acids lying
on one side separated from the charged amino acids by a
well-defined hydrophobic plane. Recent solution NMR ex-
periments by Michalek et al. (35) further unveiled the atomic
structure of Htt17 in a DPCmicelles solution, showing that it
forms a well-structured a-helix from residues 6 to 17, while
the first five residues are disordered. After these results, the
orientation of this model on POPC bilayers has been deter-
mined using the 15N chemical shifts of Leu7, Phe11, and
Phe17 as well as the deuterium quadrupolar splitting of
2H3-Ala
10 obtained by solid-state NMR (45). The Htt17
insertion depth on a phospholipid bilayer has also been
recently investigated from the fluorescence intensity quench-
ing of three key residues (Met1, Phe11, and Phe17) mutated to
tryptophan (46). Other experiments focused on the mem-
brane interactions of Htt17 when linked to QN revealing,
for instance, that Htt17 is crucial for QN binding and aggre-
gation on membrane bilayers (47), and that it binds more
favorably to curved (48) and acidic phospholipid-containing
(49) bilayers as the QN segment’s length increases (49,50).
The structure and dynamics of Htt17 on a phospholipid
membrane at the atomic level has also been investigated
using atomistic molecular dynamics (MD) simulations.
The binding of Htt17, Htt17Q10, and Htt17Q20 as well as
their stability as an a-helix on a POPE membrane has
been simulated (41). Upon binding to the membrane, the
Htt17 segment partitions its nonpolar amino acids inside
the hydrophobic core of the membrane, while QN remains
above the phospholipid headgroups. The role of the QN
region is to stabilize the Htt17 membrane anchor, easing
its insertion as a stable single a-helix in agreement with
previous experimental observations (35,45). Another group
focused on the binding of KKQ35KK, KKQ35P11KK,
Htt17Q35KK, and Htt17Q35P11KK from disordered states
on a DOPC bilayer (43). They observed that binding of these
sequences leads to perturbations of the bilayer physicalBiophysical Journal 108(5) 1187–1198properties. Htt17 enhances the membrane interactions of
huntingtin N-terminal in agreement with previous experi-
ments (47). Both of these computational studies show that
Htt17 folding on a bilayer from disordered states occurs
beyond the microsecond timescale and involves a slow
configurational change (41,43).
With the publication of the NMR model (35,45), we
decided to refine the atomistic picture of Htt17 interactions
and dynamics on a POPC bilayer using all-atom MD and
Hamiltonian replica-exchange (HREX) simulations. We
specifically analyze questions of fundamental importance
that still need to be addressed.
1. Is the NMR model obtained in the presence of DPC
micelles more structured on a POPC bilayer?
2. What are the most significant Htt17-membrane inter-
actions?
3. What is the insertion depth of each residue?
4. What are the bilayer perturbations induced by a struc-
tured Htt17 membrane anchor?
Such knowledge is valuable to gain understanding of the
atomistic basis of huntingtin interaction with membrane-
containing organelles of the cell through its amino-terminus
membrane anchor (Htt17). It further provides the necessary
information to develop rationales for modulating the local-
ization and aggregation of huntingtin in the cell at the
atomic level.MATERIALS AND METHODS
In this study, we combine MD and HREX simulations, respectively, of
26 and 20 ms in total, as summarized in Table 1, to investigate the con-
figurational ensemble of the 17-amino-acid amino-terminus segment
(Htt17) of the huntingtin protein on a POPC (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine) bilayer. The amino acids sequence of Htt17 is
MATLEKLMKAFESLKSF-NH2, where we use an amidated carboxy-ter-
minus as in the NMR experiments to which we compare and then combine
our results (35,45).
All simulations are performed using the GROMACS software (ver. 4.6.5)
(51–54) combined with the PLUMED plug-in (ver. 2.0.2) for the HREX
FIGURE 1 Per-residue a-helix probability of Htt17. Results for the MD
simulations starting from a single a-helix and the NMR model determined
in the presence of DPC micelles are respectively shown by blue squares and
green diamonds. (Black triangles) HREX simulation. Initially, according to
STRIDE (60), the NMR model has an a-helix from residues 6 to 16 and the
a-model from residues 2 to 6. The HREX simulation is launched from the
a-model. The value and the error bar measurements for each residue are,
respectively, the average and the standard deviation over all the averages
on the 250–1000 ns time interval obtained from 11 independent MD simu-
lations (Table 1). For HREX, the average and standard deviation are
computed at the unscaled replica on the 50–250 ns time interval using
20-ns time windows. See Figs. S2 and S3 for the results on the two addi-
tional HREX simulations starting from the single a-helix at different inser-
tion depths and the one starting from the NMR model, respectively. To see
this figure in color, go online.
Htt17 on a POPC Bilayer 1189simulations (55,56). The AMBER99sb*-ILDN protein force field (57) is
combined with the Berger phospholipid force field (58) as justified in the
Supporting Material. The HREX algorithm enhances the sampling by
executing simultaneous simulations called replicas with different Hamilto-
nian (energy) that can exchange, at a given frequency, as specified by the
REST2 protocol for which only protein/protein and protein/solvent interac-
tions are scaled (59). In our work, the solvent is the water molecules and
phospholipids; therefore, water/water, water/phospholipids, and phospho-
lipids/phospholipids interactions are not scaled. This protocol has been
tested on Trp-cage and a b-hairpin showing a significantly lower computa-
tional cost and better sampling than temperature replica exchange (59).
Moreover, contrary to temperature replica exchange, this method enhances
the sampling of the conformational space at room temperature, which is a
necessary condition to conserve the integrity as well as the physical prop-
erties of the phospholipid bilayer. For our HREX simulation, we use 16
scales generated by a geometric distribution (and numbered from 1 to 16
in the following order): 1.0, 0.92, 0.85, 0.79, 0.73, 0.67, 0.62, 0.57, 0.53,
0.49, 0.45, 0.41, 0.38, 0.35, 0.33, and 0.3. An exchange between each
neighboring scale is attempted every 2 ps, resulting in an exchange rate
of 10–30%. More details on this method and on our simulation parameters
are provided in the Supporting Material.
The simulations performed in this article are summarized in Table 1. We
use two initial states: the NMR model obtained in the presence of DPC mi-
celles (PDB 2LD2) (35), and a single a-helix. The NMR model that we use
is the third structure in the PDB 2LD2 because it best satisfies the chemical
shift constraints obtained by solid-state NMR on a POPC bilayer (45). The
other structures are very similar to the third one as STRIDE (60) shows that
they all populate disordered configurations from residues 1 to 5 and an a-
helix from residues 6 to 16 (35). For its part, the single a-helix, as its
name indicates, has a single a-helix running from residues 2 to 16. We
use the INFLATEGRO2 procedure with the standard parameters (61) to re-
move all atomic clashes of the inserted Htt17. Initially, the center-of-mass
distance between the backbone atoms of residues 6–17 and the bilayer is
1.8 nm, and the Htt17 lies parallel to the surface of the membrane with
its nonpolar residues facing the hydrophobic core of the membrane. We
also tested two additional initial positions at 2.0 and 2.5 nm using HREX
simulations only. Each MD trajectory and HREX simulation starts from a
different velocity distribution after an energy minimization and an NPT
equilibration of 10 ns.RESULTS
In this section, we analyze more specifically three simu-
lation sets: 11-MD simulations starting from the NMR
model (Htt17_nmr), and two separate 11-MD and HREX
simulations starting from a single a-helix (Htt17_a and
Htt17_a_hrex, respectively) as summarized in Table 1. We
compare, discuss, and combine our results with the experi-
mental measurements obtained by solid-state and two-
dimensional solution NMR (35,45) as well as fluorescence
(46) spectroscopy. Further comparisons with experimental
studies are postponed to the Discussion.Htt17 structural stability
We observe that Htt17 remains largely a-helical, particu-
larly from residues 7 to 16 in the three simulation sets,
with a probability >50% as shown in Fig. 1. The two
initial states evolve differently, however. While the NMR
model (Htt17_nmr) loses helicity and shows significant
fluctuation at residues 6–9, the single a-helix (Htt17_aand Htt17_a_hrex) is much better preserved overall with a
per-residue a-helical probability >80% for residues 2–15
with only very small fluctuations. The efficiency of the
sampling-enhancing HREX simulation is supported by the
fact that the replicas diffuse well (10–30% of exchange
acceptance) and that the peptide unfolds at larger scales
corresponding to reduced interactions (see Fig. S1 in the
Supporting Material). Furthermore, starting from different
insertion depths does not change the innate stability of the
a-helix, which converges to the same equilibrium values
for secondary structure, water accessibility, insertion depth,
and membrane properties (Fig. S2).
By comparison with the single a-helix, the NMRmodel is
less stable as indicated by the relatively large error bars at res-
idues 6–9. This can be explained by the fact that the helical
structure unfolds (turn-and-coil) for these residues in some
of the MD trajectories. A HREX simulation starting from
the NMRmodel (Htt17_nmr_hrex) shows evenmore unfold-
ing of the conformation initially (Fig. S3). Interestingly,
however, the Htt17 refolds in this simulation toward a single
a-helix near the end of the simulation. The sampling
enhancing technique HREX seems, in contrast to the MD
simulations, to be efficient enough to refold theHtt17 peptide
on the bilayer. A longer simulation time, as of this writing
beyond our accessible computational resources, will be
needed to reach convergence and confirm this observation.
These results suggest that Htt17 could be more struc-
tured on a bilayer than the micelle NMR model, whichBiophysical Journal 108(5) 1187–1198
1190 Coˆte´ et al.has rather flexible amino-terminus residues (35). This is
supported by tryptophan fluorescence results, indicating a
relatively deep penetration of the first residue of Htt17
(46). Moreover, solid-state NMR measurements of Htt17
reconstituted into oriented phospholipid bilayers show a
small nonzero 2H splitting for Ala2, suggesting structure/
interaction with the membrane (E.S.S. and B.B., unpub-
lished observation). This small splitting could either be
due a high degree of motion and/or an alignment of the
Ca-Cb vector close to the magic angle. Our simulations
also find, in agreement with solid-state NMR (ssNMR), a
small quadrupolar splitting for Ala2 (Table 2). This con-
firms that the magnitude of this value is due in part to a
stable a-helical conformation around this residue, and in
part to a higher degree of motions for Ala2 compared to
residues 6–15, as indicated by the fluctuations in the a-he-
lical content (Fig. 1).
As expected, the remaining part of the structure, which
forms a stable a-helix, is very similar to the solution
NMR model (35,45) with a backbone root-mean-square de-
viation on residues 6–16 of 0.11 5 0.07 nm (Htt17_nmr),
0.07 5 0.01 nm (Htt17_a), and 0.07 5 0.01 nm
(Htt17_a_hrex). We also note that residue 17 could be
considered part of the helix, because main-chain hydrogen
bonds between this residue and residues 13 or 14 are popu-
lated 68 5 5% of the time in Htt17_nmr, 70 5 4% in
Htt17_a, and 69 5 7% in Htt17_a_hrex. This is in agree-
ment with the NMR spectra that show nuclear Overhauser
effects up to residue 17 and the ssNMR spectra that exhibits
an anisotropic 15N chemical shift at this residue (35,45).Htt17 orientation
In terms of orientation, we compare our simulations to
ssNMR measurements on the 15N chemical shifts of Leu7,
Phe11, Leu14, and Phe17, and the 2H3 quadrupolar splittings
of Ala2 and Ala10 of Htt17 on a POPC bilayer (35,45). These
values depend, respectively, on the orientation of the C–N
and N–H bonds (15N), and the Ca-Cb bond (
2H) with respect
to the bilayer normal that is aligned in the same direction as
the magnetic field (62–64). The computations are described
in detail in the Supporting Material.TABLE 2 Orientation of Htt17 on the bilayer
Simulations 2H3-Ala
2 kHz 15N-Leu7 ppm 2H3-Ala
10 kHz 15N-Phe
Htt17_nmr 145 20 1105 28 265 12 91 5
Htt17_a 75 10 715 2 305 6 85 5
Htt17_a_hrex 45 7 685 3 275 8 84 5
ssNMR (exp) 55 2 71.25 1.7 11 5 2.5 78.95
The 15N chemical shifts of Leu7, Phe11, Leu14, and Phe17 as well as the 2H3 quad
the membrane anchor on the bilayer in terms of tilt and rotational pitch angles (62
the tilt and pitch angles were determined for the NMR structure of Htt17 in the p
error bar are, respectively, the average and the standard deviation over all the av
ulations (Table S1). For the HREX simulation, the average and standard deviatio
20-ns time windows. See Table S1 for the results on the two additional HREX
Biophysical Journal 108(5) 1187–1198The averaged chemical shifts and quadrupolar splittings
sampled during the Htt17_nmr, Htt17_a, and Htt17_a_
hrex simulations are presented in Table 2. The 15N-Phe11,
15N-Leu14, and 15N-Phe17 chemical shifts and the 2H3-
Ala2 quadrupolar splitting for the three simulation sets
show good agreement with ssNMR measurements. The
signal for 15N-Leu7 favors instead the a-helical configura-
tion over the NMR model that becomes disordered around
this residue in our simulations (Htt17_nmr in Fig. 1).
Strangely, however, the 2H3-Ala
10 quadrupolar splitting
sampled in the three simulation sets is significantly larger
than the experimental measurement. Using a different force
field (AMBER99sb*-ILDN/SLIPIDS) yields a value for the
2H3-Ala
10 quadrupolar splitting that is closer to the exper-
iment, but that is still different (175 1 vs. 115 1 kHz for
ssNMR; see Table S1 in the Supporting Material). For
the single a-helix, this difference could be due to very
local structural fluctuations of modest amplitude because
the chemical shifts of Ala10’s neighboring residues (15N-
Leu7, 15N-Phe11, and 15N-Phe17) agree with the experi-
mental values. Moreover, this part of the peptide samples
similar secondary structure propensity in all simulations,
suggesting a very stable global conformation (Fig. 1).
These observations are reinforced by two supplementary
HREX simulations starting from a less inserted single a-
helix that yield very similar chemical shifts and quadrupo-
lar splitting (Table S1).
We can further describe the orientation of Htt17 on a
bilayer in terms of the tilt and rotational pitch angles as
shown in Table 2. These angles are defined as a rotation
of Htt17 structure’s amphipathic plane, initially in the x,z
plane, around the negative z axis (rotational pitch) followed
by the rotation around the negative y axis (tilt) as shown
in Fig. 2 A. Using this definition, a rotation of 90 tilt and
90 pitch results in the hydrophobic plane being parallel
to the membrane surface (x,y plane). These angles can be
extracted by the values of 15N chemical shifts and 2H
quadrupolar splitting. In particular, the tilt angle depends
more strongly on the 15N shift (62). Here, the good agree-
ment between simulations and ssNMR in the 15N chemical
shifts indicates that the helix axis of Htt17 has an in-plane
orientation in the membrane (Table 2).11 ppm 15N-Leu14 ppm 15N-Phe17 ppm Tilt degree Pitch degree
3 77 5 6 805 15 945 5 765 5
1 66 5 1 875 4 875 5 855 5
1 65 5 2 925 5 915 5 955 5
1.5 73.35 1.2 88.25 0.9 1035 5 1375 5
rupolar splittings of Ala2 and Ala10 are used to extrapolate the orientation of
–64). The ssNMRmeasurements of Htt17 were done on a POPC bilayer and
resence of DPC micelles (35,45). For the MD simulations, values and their
erages on the 250–1000 ns time interval obtained from 11 independent sim-
n are computed at the unscaled replica on the 50–250 ns time interval using
simulations starting from the single a-helix at different insertion depths.
FIGURE 2 Representative structure of the average orientation of Htt17
on a POPC bilayer from the MD trajectory Htt17_a. The corresponding
15N chemical shifts would be 71 (Leu7), 85 (Phe11), and 87 (Phe17) ppm,
and the 2H3-Ala
10 quadrupolar splitting is 30 kHz corresponding to a tilt
angle of 87 5 5 and rotational pitch angle of 85 5 5. (A) Graphical
definition of the tilt and rotational pitch angles, (B) view from the
carboxy-terminus, (C) view from the side, (D) view from the membrane,
and (E) view from the aqueous solution. The nonpolar (yellow), negatively
charged (blue), positively charged (red), and polar (green) amino acids of
Htt17. (Black) Backbone atoms; (pink) amino- and (teal) carboxy-terminus.
To see this figure in color, go online.
Htt17 on a POPC Bilayer 1191The rotational pitch angle, for its part, is a more difficult
quantity to extract because it depends on the 2H quadrupolar
splitting, a value that is very sensitive upon local structural
changes as observed from experiments and simulations
(65,66). In our simulations, the hydrophobic plane of Htt17
is orientedparallel to themembrane surface (pitch~90) as ex-
pected for an amphipathic monomer such as Htt17 (63). This
value differs significantly from the experimentally determinedpitch angle (137), which suggests that the charged residues of
Htt17 are preferentially oriented toward the right when look-
ing along the helix axis through the carboxy-terminus (such a
point of view is shown in Fig. 2 B). This asymmetrical orien-
tation was justified by the possible formation of Htt17 dimers
on the bilayer during the ssNMR experiment through electro-
static interactions (35,45). However, introducing small
conformational changes to the micellar NMR structure could
also result in a more symmetric alignment while at the same
time satisfying all solid-state NMR constraints.
Our simulations can be further used to characterize the
global motion of the Htt17 helix. We observe that the
wagging motion along the helix long axis spreads by a stan-
dard deviation of ~8–10, while the wobbling motion
around the helix long axis spreads by a standard deviation
of ~14 (data not shown). These angular deviations are
quite close to those used for the restriction analysis of the
solid-state NMR data where standard deviations of 10 and
18, respectively, were used for the analysis (35,45). This
motional regime used for the analysis of tilt and pitch angles,
which is confirmed by the MD results, better represents the
situation in a liquid crystalline bilayer than does a completely
static peptide, which led to differences of up to ~5.Htt17 interactions with the bilayer
After characterizing Htt17’s structural and topological
properties, we now examine its interactions with the
POPC bilayer. In terms of solvent accessibility, we observe
the sequestration of key nonpolar residues such as Leu7,
Phe11, Leu14, and Phe17 for the three simulation sets
(Fig. 3). Moreover, residues involved in frequent hydrogen
bonds or salt-bridges with the phosphate group of the phos-
pholipids (Lys6, Ser13, and Lys15, see Table 3) are also more
isolated from the solvent. As expected, those that weakly
interact with the bilayer (Glu5, Lys9, and Glu12) are highly
accessible to the solvent. For the Htt17_a and Htt17_a_hrex
simulations, residues 1–4 are less accessible to the solvent
compared to Htt17_nmr for which these residues are and
stay disordered (Fig. 1). Measurements of Htt17 insertion
depth in the bilayer support these observations (Fig. 3).
Our simulations can be combined with recent experi-
mental observations (45,46). First, the addition of hydro-
philic (Mn2þ ions) or hydrophobic (16-doxyl-stearic acid)
paramagnetic relaxation reagents in the presence of DPC
micelles indicate that residues Leu7, Met8, Ala10, and
Phe11 of Htt17 are oriented toward the hydrophobic environ-
ment of the micelle (45). Our results correlate well with
these measurements and confirm that these residues are
also strongly involved in the association of Htt17 with a
POPC bilayer (Fig. 3). Second, using fluorescence intensity
quenching, the insertion depth of residues Met1, Phe11, and
Phe17 mutated to tryptophan was measured in the presence
of POPC-POPS vesicles containing brominated POPC lipids
(46). The relative positions of M1W, F11W, and F17WBiophysical Journal 108(5) 1187–1198
FIGURE 3 Solvent accessibility and insertion depth of each residue of
Htt17. (Top panel) (Left-hand side axis) The solvent accessibility is quan-
tified in terms of the number of water molecules within 0.35 nm from
each residue. (Right-hand side axis) Residual amplitude quotient due to
the addition of hydrophilic (Mn2þ ions) and hydrophobic (16-doxyl-stearic
acid) paramagnetic relaxation reagents on Htt17 in the presence of DPC
detergent micelles (45). A larger residual amplitude quotient indicates a
larger solvent accessibility of the side chain. (Bottom panel) The insertion
depth corresponds to the center-of-mass distance between each side chain
and the bilayer along the direction perpendicular to the membrane surface
(z axis). (Dotted line at 1.8 nm) Average position of the phosphorous atoms
of the upper leaflet with respect to the center of the bilayer. The experi-
mental values were measured using fluorescence quenching of Htt17 tryp-
tophan mutants in the presence of POPC/POPS vesicles containing
brominated POPC lipids (46). Results for the MD simulations starting
from the NMRmodel (green diamonds) and a single a-helix (blue squares).
The HREX simulation (black triangles) and the average position (orange
triangles) of the aromatic rings obtained from direct M1W, F11W, and
F17W mutations on the wild-type trajectory. The value and the error bar
for each residue, are respectively, the average and the standard deviation
over all the averages on the 250–1000 ns time interval obtained from 11 in-
dependent MD simulations (Table 1). For HREX, the average and standard
deviation are computed at the unscaled replica on the 50–250 ns time inter-
val using 20-ns time windows. See Fig. S2 for the results on the two addi-
tional HREX simulations starting from the single a-helix at different
insertion depths. To see this figure in color, go online.
1192 Coˆte´ et al.in Htt17 were measured to 1.12 5 0.14 nm, 0.73 5
0.12 nm, and 1.085 0.12 nm, respectively, from the center
of the bilayer. Our results from the Htt17_a and Htt17_a_h-
rex simulations agree with the measurement on Met1, while
Phe17 and Phe11 are slightly farther from the bilayer center
in our simulations (Fig. 3). Because the tryptophan fluores-
cence transition dipole is probably associated with the aro-
matic ring only, we now investigate the effect of having
tryptophan instead of the wild-type residues on the insertion
depth measurements. To do this, we performed the M1W,
F11W, and F17W mutations in the Htt17_a_hrex wild-
type trajectories and optimized the side-chain orientationBiophysical Journal 108(5) 1187–1198using SCRWL4 (67). Of course, structural/topological alter-
ations could be introduced by the mutations themselves, but
simply taking into account the tryptophan side chain’s
geometry leads to 1.13 5 0.09 nm (M1W), 0.93 5
0.07 nm (F11W), and 1.32 5 0.07 nm (F17W), which is
in better agreement with the experimental measurements.
Two supporting HREX simulations starting from a single
a-helix at different insertion depths (2.0 and 2.5 nm from
the bilayer’s center, compared to 1.8 nm previously)
converge to the same equilibrium values (Fig. S2).
The Htt17 membrane anchor has six residues that can
form side-chain hydrogen bonds as donors—Thr3, Lys6,
Lys9, Ser13, Lys15, and Ser16—with the oxygens of the phos-
phate group and the carboxyl groups of POPC. The average
number and occurrence probability of H-bonds are shown in
Table 3. Ordering these residues in terms of their propensity
to form H-bonds yields the following: Ser16 < Thr3 <
Ser13 < Lys9 < Lys6 ( Lys15 in Htt17_nmr, Ser16 <
Lys9 < Ser13 < Thr3 < Lys15 ( Lys6 in Htt17_a, and
Ser16 < Lys9 < Thr3 < Ser13 < Lys15 < Lys6 in Htt17_a_
hrex. For the two initial states, Ser16 shows the lowest H-
bond occurrence probability with only 10%, while Lys6
and Lys15 form H-bonds >85% of the time. Two supporting
HREX simulations starting from a single a-helix at different
insertion depths (2.0 and 2.5 nm from the bilayer’s center,
compared to 1.8 nm previously) converge to a similar
hydrogen-bond interaction pattern (Table S2).
The positively charged lysines of Htt17 also form salt-
bridges with the negatively charged phosphate group of
the phospholipids. With occurrence probabilities ranging
from 28 to 60%, we see that such salt-bridges are a key
component of the interactions between Htt17 and the bilayer
(Table 3). Moreover, these residues can participate in up
to three salt-bridges with different phospholipids. In order
of occurrence probability, we find Lys9 < Lys6 ( Lys15 in
Htt17_nmr, and Lys9 < Lys15 < Lys6 for the single a-helix
in both Htt17_a and Htt17_a_hrex. While Lys9 has a lower
probability to form salt-bridges with the phospholipids,
contrary to the other lysines it often forms intramolecular
salt-bridges with either Glu5 or Glu12 (Table S4). In princi-
ple, the negatively charged glutamic acids of Htt17 could
form salt-bridges with the positively charged nitrogen of
the choline group. However, the occurrence probability for
such salt-bridges is very low (1–2%) because the three
methyl groups surrounding the nitrogen cause steric hin-
drance to the salt-bridge formation (Table 3). Two support-
ing HREX simulations starting from a single a-helix at
different insertion depths (2.0 and 2.5 nm from the bilayer’s
center, compared to 1.8 nm previously) converge to a similar
salt-bridge interaction pattern (Table S3).DISCUSSION
The first 17 amino acids at the amino-terminus (Htt17) of
huntingtin, a large protein related to Huntington’s disease
TABLE 3 Average number of hydrogen bonds and salt-bridges between Htt17 and the phospholipids of the membrane
Interaction type Residue Htt17_nmr number (%) Htt17_a number (%) Htt17_hrex number (%)
Hydrogen bonds Thr3 0.95 0.3 (145 19) 1.0 5 0.0 (61 5 30) 1.05 0.0 (515 30)
Lys6 1.85 0.3 (855 17) 1.9 5 0.2 (925 4) 2.25 0.2 (955 5)
Lys9 1.45 0.2 (565 19) 1.4 5 0.2 (38 5 11) 1.15 0.1 (325 9)
Ser13 1.05 0.0 (455 22) 1.0 5 0.0 (545 8) 1.05 0.1 (545 19)
Lys15 1.85 0.3 (865 8) 1.7 5 0.1 (905 4) 1.75 0.2 (905 3)
Ser16 1.05 0.0 (95 5) 1.0 5 0.0 (65 2) 1.0 5 0.1 (55 4)
Salt-bridges Glu5 0.95 0.3 (15 2) 1.0 5 0.0 (15 1) 1.0 5 0.1 (15 1)
Glu12 0.95 0.3 (15 1) 1.0 5 0.0 (15 0) 1.0 5 0.0 (15 1)
Lys6 1.15 0.1 (495 11) 1.2 5 0.1 (605 8) 1.35 0.2 (655 20)
Lys9 1.25 0.1 (405 13) 1.1 5 0.0 (285 5) 1.15 0.1 (285 7)
Lys15 1.15 0.1 (515 8) 1.1 5 0.1 (485 9) 1.05 0.1 (385 10)
For a given residue, statistics are performed only over the frames in which the residue forms at least one H-bond or salt-bridge. The numbers in parentheses
represent the probability of occurrence in percentage. The value and the error bar for each residue are, respectively, the average and the standard deviation
over all the averages on the 250–1000 ns time interval obtained from 11 independent MD simulations (Tables S2 and S3). For the HREX simulation, the
average and standard deviation are computed at the unscaled replica on the 50–250 ns time interval using 20-ns time windows. See Tables S2 and S3 for
the results on the two additional HREX simulations starting from the single a-helix at different insertion depths.
Htt17 on a POPC Bilayer 1193and with multiple biological functions (5–9), modulate its
localization, function, aggregation, and degradation in the
cell (20–29). For instance, the amphipathic character of
the Htt17 segment is responsible for huntingtin’s membrane
anchoring properties and regulates its interaction with spe-
cific membrane-containing organelles of the cell (20).
Recently, solution NMR has been used to resolve the struc-
ture of Htt17 in the presence of DPC detergent micelles
(35). Solid-state NMR further unveiled its orientation on a
POPC bilayer using 15N chemical shift and 2H quadrupolar
splitting measurements (45).
The MD and HREX simulations described in this article
are combined with these NMR measurements to yield the
first high-resolution model for the membrane-anchoring
properties of the Htt17 segment of huntingtin. Our results
refine the atomistic picture of Htt17 on a phospholipid
bilayer in terms of its structure, orientation, key membrane
interactions (hydrogen bonds, salt-bridges, insertion depth,
and solvent accessibility), and membrane perturbations
(order parameter, area per lipid, and thickness), as well as
the influence of the phospholipid type on those observations.
We now discuss each finding and their implications in detail.The Htt17 monomer forms a stable a-helix on a
POPC bilayer
In aqueous solution, the Htt17 monomer is mostly disor-
dered as shown by solution NMR (24), while CD spectros-
copy suggests that it can form transient helical structures
(20,24,34,35). Transition to a stable a-helix occurs upon
self-association (31) as well as upon addition of phospho-
lipid vesicles, detergent micelles, or apolar compounds to
an aqueous buffer (20,24,35). Recently, the structure of
Htt17 in the presence of DPC micelles has been resolved
using solution NMR spectroscopy: it is disordered from res-
idues 1 to 5 and it is an a-helix for the rest of the sequence
(35). Despite indirect indications from ssNMR (45), it hadnot yet been verified whether Htt17 adopts exactly the
same structure on a phospholipid bilayer.
Our simulations extend previous observations by showing,
with many independent MD and HREX simulations, that
the first residues of Htt17 also form a stable a-helix on a
POPC bilayer (Fig. 1). Moreover, the 15N chemical shifts
of Leu7, Phe11, and Phe17 sampled during those simulations
agree with solid-state NMR measurements of Htt17 on a
POPC bilayer (45) (Table 2). These values are consistent
with an in-plane orientation of the amphipathic Htt17 with
respect to the membrane surface, as depicted in Fig. 2. Our
observations are further supported by very similar results
obtained in terms of structure (Fig. S4) and chemical shifts
(Table S1) using a different force field (AMBER99sb*-
ILDN/SLIPIDS, Table 1).
The increased stability of the Htt17 monomer as an
a-helix due to the presence of a phospholipid bilayer could
have a strong impact on its oligomerization. In aqueous
solution, Htt17 is mostly disordered at the monomeric level
as shown by solution NMR experiment (24), but it forms
a stable tetrameric bundle of four a-helical Htt17 (31).
When linked to the polyglutamine segment (QN) that
follows Htt17 in huntingtin’s sequence, the aggregation
pathway of QN is significantly modified (31,32). More
precisely, Htt17QN has two main aggregation pathways in
direct kinetic competition: 1) one is initiated by the forma-
tion of a-helical tetrameric bundles of Htt17 that combine to
form larger oligomeric assemblies favoring QN fibrillation
due to an increase in its local concentration, and 2) the other
is independent of structure formation in Htt17 resulting in
an aggregation pathway that is very similar to QN alone
(32). The first pathway yields faster fibrillation kinetics
(24,30).
Here, we observe that the Htt17 monomer forms a stable
a-helix on the bilayer (Fig. 1) that is significantly different
from its mostly disordered structure in aqueous solution as
observed from other simulations using the same force fieldBiophysical Journal 108(5) 1187–1198
1194 Coˆte´ et al.(41). The presence of the membrane favors the formation of
a-helical structures in Htt17 that could then ease the nucle-
ation of the a-helical tetrameric bundle of Htt17. Conse-
quently, the oligomerization and fibrillation kinetics of
Htt17QN could be enhanced by the presence of a phospho-
lipid bilayer (35) as for other amyloidogenic proteins (68).
On the membrane, as observed from MD simulations, the
QN region of Htt17QN and Htt17QNP11 is indeed easily
available for aggregation, because it lies on the surface of
the phospholipid heads (41,43) and weakly interacts with
Htt17 (41). The converse argument is also possible: the for-
mation of oligomeric structures containing an a-helical
Htt17 before its binding on the phospholipid bilayer could
favor its insertion. Indeed, previous simulations suggest
that the complete partitioning of Htt17 nonpolar residues
is eased by the presence of a-helical structures before bind-
ing, while the reordering of disordered structures on the
bilayer are impeded by strong electrostatic interactions be-
tween Htt17 and the phospholipids (41).The key residues for Htt17-membrane interaction
are crucial to huntingtin’s function
The Htt17 segment of huntingtin is involved in several
posttranslational modifications such as SUMOylation
(25) and phosphorylation (26–29) that are crucial to its
physiological and pathological functions. More precisely,
SUMOylation implicating Lys6 and Lys9 correlates
with increased neurodegeneration in Drosophila, possibly
through the modulation of huntingtin localization and
aggregation (25). Phosphorylation of Ser13 and Ser16
increases huntingtin clearance, reduces the toxicity in a
mouse model, regulates other posttranslational modifi-
cations of Htt17, and increases nuclear localization of hun-
tingtin (26,28,29). Phosphorylation of Thr3 increases the
formation of insoluble aggregates and a phosphomimetic
mutation of the threonine to an aspartic acid reduces the
neurodegeneration in Drosophila (27). Mutations or trunca-
tions of the nonpolar residues implicated in the nuclear
export signal of Htt17—L4, L7, F11, and L14—lead to a
significant increase of huntingtin accumulation in the nu-
cleus (20,22,69). Neutralization of the lysines and glutamic
acids by substitution to alanines modulates the membrane
composition targeted by Htt17 (20).
In our simulations, we observe that many of these crucial
residues are involved in specific interactions with the
phospholipids. For instance, salt-bridges between Lys6
and Lys15 and the phospholipids occur often, while Lys9
is mainly involved in intramolecular salt-bridges with
either of the two glutamic acids in Htt17 (Tables 3 and
S4). These charged residues as well as Ser13 also regularly
form hydrogen bonds with the phospholipids (Table 3).
Moreover, nonpolar sequestration of L7, F11, and L14
inside the hydrophobic core of the membrane is crucial to
the anchoring of Htt17 (Fig. 3). Our observations are rein-Biophysical Journal 108(5) 1187–1198forced by similar results in terms of solvent accessibility
(Fig. S5), insertion depth (Fig. S6), hydrogen bonds
(Table S2), and salt-bridges (Table S3) using a different
force field (AMBER99sb*-ILDN/SLIPIDS, Table 1). Our
simulations therefore suggest that perturbation of these
key membrane interactions (Table 3 and Fig. 3) will likely
impact Htt17’s ability for membrane binding in various
ways, consequently affecting huntingtin localization in the
cell and potentially its function.The network of electrostatic interactions depends
on the phospholipid type, but not the
configuration of Htt17
The structure and orientation of Htt17 remain almost un-
changed when inserted in membranes of different composi-
tion as shown from solution NMR, solid-state NMR, and
CD spectroscopy (35). In contrast, the ability of this mem-
brane anchor to target phospholipid vesicles highly depends
in the membrane composition as shown from the binding
affinity extrapolated from CD measurements and trypto-
phan-emission fluorescence (35,46). More precisely, Htt17
binds more favorably to membranes containing anionic
phospholipids such as PS and PG than to the zwitterionic
PC, while the presence of cholesterol has the opposite
effect. A similar behavior has also been observed for the
exon 1 of huntingtin (49).
We can compare our results on a POPC bilayer to a previ-
ous study in which we investigated Htt17 on a POPE bilayer
using MD simulations (41). Because these simulations were
done using the AMBER99sb*-ILDN/SLIPIDS force field,
we compare them to the results on the POPC bilayer
obtained using the same force field (Table 1). In each case,
we have two simulations of 500 ns each for POPE and of
1000 ns each for POPC starting from different velocity
distributions. Htt17 is initially a single a-helix inserted in
the bilayer below the phosphate group of the phospholipids.
We observe that Htt17’s structure (Fig. S7) and orienta-
tion (Table S5) are quantitatively similar in the zwitterionic
POPC and POPE bilayers. In contrast, the insertion depth of
Htt17 (Fig. S8) and its network of salt-bridges and hydrogen
bonds with the phospholipids (Table S6) are different. More
precisely, the main difference is that the glutamic acids
(Glu5 and Glu12) form salt-bridges and hydrogen bonds
with the amine group of PE, while such interactions are
not present for the choline group of PC. This shifts Htt17
nearer from the phospholipid heads without changing sig-
nificantly its solvent accessibility. In the previous simula-
tions on POPE, we also observed that electrostatic
interactions initialize the binding of Htt17 on the phospho-
lipid bilayer (41).
Taken together, experiments and simulations suggest
that the main interaction responsible for the structure and
orientation of Htt17 is the sequestration of its nonpolar
residues in the hydrophobic core of the membrane, as
Htt17 on a POPC Bilayer 1195this is independent of the phospholipid species. In contrast,
the binding affinity of Htt17 on phospholipid bilayers
appears to depend on specific electrostatic interactions
that are modulated by the membrane composition. The
main role of the charged residues could be to target selec-
tively membrane with specific phospholipid compositions.
Indeed, experiment shows that mutating the charged resi-
dues to alanines can change the localization of huntingtin
in the cell (20).
Besides the phospholipid type, the presence of cholesterol
also has an impact: increasing its concentration significantly
impedes Htt17’s ability to bind and permeabilize phospho-
lipid membranes (35,46). As discussed in the next section,
our simulations show that Htt17 induces local perturbations
in the physical properties of the bilayer such as membrane
thinning, reduced phospholipid area, and decreased phos-
pholipid order parameters (Fig. 4). These perturbations are
due to the neighboring phospholipids of Htt17 extending
their acyl chains to cover its nonpolar surface (Fig. 4).
Experiment show that the effect of cholesterol is the
opposite: it increases the order of the phospholipid acyl
chains and the membrane thickness. And by doing so, the
cholesterol might protect the membrane from accommoda-
ting the binding state of the Htt17 monomer, thereby
reducing its binding affinity and further oligomerization in
the membrane.FIGURE 4 Perturbations of the bilayer properties by Htt17. Results for
Htt17_a (blue squares) and Htt17_a_hrex (black triangles). (A) Average
order parameters of the palmitic chain carbons of the neighboring (dotted)
and then total (line) phospholipids. The neighboring phospholipids are
defined as those within 1.0 nm of Htt17 in the upper leaflet. (B) Average
membrane thickness computed using GRIDMAT (70) and (C) average
area per phospholipid computed using VTMC (71) as a function of their
distance from Htt17. (For panels B and C, the black dotted line represents
the averaged value for a simulated POPC bilayer without Htt17.) The value
and the error bar for each residue are, respectively, the average and the
standard deviation over all the averages on the 250–1000 ns time interval
obtained from 11 independent MD simulations (Table 1). For the HREX
simulation, the average and standard deviation are computed at the unscaled
replica on the 50–250 ns time interval using 20-ns time windows. See
Fig. S2 for the results on the two additional HREX simulations starting
from the single a-helix at different insertion depths. To see this figure in co-
lor, go online.The Htt17 monomer locally perturbs the physical
properties of the bilayer
Experiments show that the presence of 2.5 mol % of Htt17
on POPC, POPE/POPG, and POPC/POPS bilayers sig-
nificantly reduces the order parameters of the phospholipid
palmitic chain (35). A few micromoles of Htt17 are suffi-
cient to induce leakage of large POPC and POPC/POPS
unilamellar vesicles (35). Globular aggregates of the exon
1 of huntingtin increase the roughness, similarly to other
amyloid protein (72), and change the mechanical properties
of total brain lipid extract bilayers, as shown by atomic force
microscopy (50).
At the monomer level, we observe that the presence of
Htt17 on a POPC membrane already leads to local pertur-
bations of the bilayer physical properties as summarized
in Fig. 4. For instance, the area per lipid and membrane
thickness are decreased within a distance of ~1 nm from
Htt17 with respect to the bulk phospholipids. This reor-
dering of the bilayer accommodates Htt17 by allowing
its neighboring phospholipids to extend their acyl chain
to cover its nonpolar surface as depicted by Fig. 2. The
resulting order parameters of these acyl chains is
decreased with respect to the membrane bulk (Fig. 4) in
agreement with other MD simulation of a disordered
KKHtt17Q35KK on a DPPC bilayer (43) and with exper-
imental measurements on a POPC bilayer with 2.5 mol %
of Htt17 (35).Theoretical studies show that such local membrane
deformations around a peptide promote dimerization of
inserted amphipathic peptides on phospholipid membranes
(73–75). This could favor the dimerization and further olig-
omerization of Htt17. Dimerization could be initiated and
stabilized by the formation of electrostatic interactions asBiophysical Journal 108(5) 1187–1198
1196 Coˆte´ et al.proposed from ssNMR orientation measurements on Htt17
(35). Our simulations indeed show that most of the charged
residues stay accessible to the solvent (Fig. 3). We expect
the rate-limiting step of such a process to be the need to
break the strong peptide-phospholipids interactions (Table
3), as some of the neighboring phospholipids of Htt17 ex-
change very slowly with the membrane bulk: ~10 phospho-
lipids stay in contact with the peptide for>400 ns and 20 for
>150 ns (Fig. S9).
After dimerization, Htt17 could then form (as observed
experimentally) larger globular aggregates that signifi-
cantly change the membrane properties (50) and cause
vesicle permeabilization (35,45). However, the preferred
mechanism of permeabilization by Htt17—pore formation,
carpet model, or detergent model (76)—remains unknown.
While pore formation of Htt17 alone is probably not
relevant for the biological activities because it is weak in
membranes with cholesterol or absent in POPE/POPG
membrane (35), it could be different in the presence of
the amyloidogenic QN region (Htt17QN). Further integrated
experimental and computational studies on this front will
be essential to compare huntingtin with the other amyloid
proteins that are known to perturb phospholipid membranes
(77,78). While the QN region can perturb on its own
the membrane integrity (79–81), from our results on the
Htt17 and Htt17QN monomers (41) and previous experi-
mental observations, we suggest a new paradigm: the role
of the amyloidogenic QN region could be to stabilize, in
a length-dependent manner, the oligomeric assemblies of
huntingtin exon 1 because it stays on the surface and is
easily accessible for oligomerization. The amphipathic
Htt17, for its part, could play a fundamental role by
initiating the binding and insertion of the monomer in
the membrane as well as by perturbing the physical prop-
erties of the bilayer in a manner to favor its oligomeriza-
tion, similarly to other a-helical amphipathic peptides
(76,82,83).CONCLUSIONS
The function and localization of huntingtin are intrinsically
dependent on the first 17 amino acids at its amino-terminus
(Htt17). This amphipathic segment serves as a membrane
anchor and is situated just before the amyloidogenic poly-
glutamine segment of huntingtin. In this study, we present
a high-resolution atomistic model of the Htt17 monomer
on a phospholipid bilayer by combining atomistic MD and
HREX simulations together with experimental results
from solution and solid-state nuclear magnetic resonance,
as well as fluorescence spectroscopy. Our model quantifies
the key interactions between Htt17 and the phospholipids
of the bilayer responsible for its structure, orientation, and
insertion depth, as well as the resulting physical perturba-
tion of the bilayer structure. It rationalizes, at the atomic
level, the potential effect of different membrane composi-Biophysical Journal 108(5) 1187–1198tions and posttranslational modifications of Htt17 on its
ability to target phospholipid bilayers. It also describes the
impact of the monomer configuration and membrane pertur-
bations on Htt17 and Htt17QN self-association into oligo-
meric complexes of potential relation to the pathogenesis
of huntingtin.
Finally, we observe that the sampling enhancing method
HREX, which enables the system to easily move out of
local minima that could bias the sampling, is ideal for
the peptide-membrane system because it is performed at
room temperature, it does not perturb the membrane phys-
ical properties, and it speeds up the convergence of the
observables. This computational method could be readily
applicable to investigate a wider variety of membrane com-
positions to precisely unveil, at the atomic level, the con-
centration dependence of cholesterol and charged
phospholipids on Htt17, Htt17QN, and Htt17QNP11 struc-
ture, orientation, key interactions, binding affinity, and
oligomerization on the surface of phospholipid membranes.SUPPORTING MATERIAL
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